Research Institute of Molecular Pathology (IMP)

Research Institute of Molecular Pathology (IMP)

Research

Website
www.imp.ac.at
Company Tagline

A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter.

Industry Category
Research
Business Keywords
Molecular Biology Cell Biology Immunology Cancer Research Developmental Biology Microscopy Computational Biology Disease Mechanisms Chromosome Biology Computational biology Gene Regulation
Company Description

The Research Institute of Molecular Pathology (IMP) is a leading biomedical research institute dedicated to advancing our understanding of fundamental molecular and cellular mechanisms. Supported primarily by Boehringer Ingelheim, the IMP fosters a collaborative environment where over 200 scientists from 40 countries explore complex biological phenomena. The Research Institute of Molecular Pathology (IMP) is located at Campus-Vienna-Biocenter 1, Vienna, 1030, AT.

The Research Institute of Molecular Pathology (IMP) focuses on a wide range of research areas, including cell and molecular biology, microscopy, immunology, cancer research, developmental biology, chromosome biology, and computational biology. With state-of-the-art facilities and a commitment to scientific excellence, the IMP plays a vital role in driving innovation and discovery in the field of molecular pathology.

Through its commitment to cutting-edge research and a collaborative scientific community, the Research Institute of Molecular Pathology (IMP) continues to contribute significantly to the global scientific landscape. We invite the management team of the Research Institute of Molecular Pathology (IMP) to enhance your online presence with a customized company showcase and product listing on our platform.

Das Forschungsinstitut für Molekulare Pathologie (IMP) ist ein führendes biomedizinisches Forschungsinstitut, das sich der Förderung unseres Verständnisses grundlegender molekularer und zellulärer Mechanismen widmet. Das IMP wird hauptsächlich von Boehringer Ingelheim unterstützt und fördert ein kollaboratives Umfeld, in dem über 200 Wissenschaftler aus 40 Ländern komplexe biologische Phänomene erforschen. Das Forschungsinstitut für Molekulare Pathologie (IMP) befindet sich am Campus-Vienna-Biocenter 1, Wien, 1030, AT.

Das Forschungsinstitut für Molekulare Pathologie (IMP) konzentriert sich auf ein breites Spektrum von Forschungsbereichen, darunter Zell- und Molekularbiologie, Mikroskopie, Immunologie, Krebsforschung, Entwicklungsbiologie, Chromosomenbiologie und Computerbiologie. Mit hochmodernen Einrichtungen und dem Bekenntnis zu wissenschaftlicher Exzellenz spielt das IMP eine entscheidende Rolle bei der Förderung von Innovation und Entdeckung auf dem Gebiet der molekularen Pathologie.

Durch sein Engagement für Spitzenforschung und eine kollaborative wissenschaftliche Gemeinschaft trägt das Forschungsinstitut für Molekulare Pathologie (IMP) weiterhin wesentlich zur globalen Wissenschaftslandschaft bei. Wir laden das Managementteam des Forschungsinstituts für Molekulare Pathologie (IMP) ein, Ihre Online-Präsenz mit einer massgeschneiderten Firmenpräsentation und Produktliste auf unserer Plattform zu erweitern.

Key Personnel / Employees
Manuel Zimmer Markus Jaritz Katharina Lust Pawel Pasierbek Edgar Kramer (Professor of Neurodegenerative Diseases at University of Plymouth)

Compare Companies Side by Side

Compare Research Institute of Molecular Pathology (IMP) with 3 companies in Research

4 Companies
Comparison Field
Research Institute of Molecular Pathology (IMP)
Research Institute of Mol...
Main Company
ZEISS arivis
ZEISS arivis
View Profile
AH diagnostics
AH diagnostics
View Profile
Cultek
Founded Year
— 2011 1986 1976
Company Size
— 51-200 11-50 51-200
City
Rostock, Mecklenburg-Vorpommern San Fernando de Henares, Community of Madrid
Country
Germany
Skills & Keywords Comparing with main company
11 Total Skills
Molecular Biology Cell Biology Immunology Cancer Research Developmental Biology Microscopy Computational Biology Disease Mechanisms Chromosome Biology Computational biology Gene Regulation
10 Total 1 Common 9 Unique
Match 9%
Common Skills:
Cancer Research
Unique Skills:
3D 4D Big Data BioMedical Imaging Collaboration Imaging +3
11 Total 11 Unique
Unique Skills:
Bio Appliance Diagnostics ELISA FISH Flow Cytometry IHC +5
5 Total 5 Unique
Unique Skills:
Equipment Genomics Immunoassay NGS Proteomics
4
Total Companies
1976
Oldest Founded
1
Countries
36
Unique Skills

Similar Companies

Other organizations in the same industry

Toseh Sazan Tabadol (TST)
Research

Provider of financial and technical investment services in international IT projects and exchanges

View Profile
Mindway Research Center in Neuroscience & Retail
Research
View Profile
Fritz-Haber-Institut der Max-Planck-Gesellschaft
Research

the FHI's catalysis research has a focus on hydrogen as green energy carrier of the future

View Profile
University of Freiburg
Research

Official LinkedIn-Page: https://www.linkedin.com/school/albert-ludwigs-universit-t-freiburg-im-bre...

View Profile

Alternative Company Names

This company is also known as

Research Institute of Molecular Pathology (IMP) 分子病理学研究所 (IMP) आणविक विकृति विज्ञान अनुसंधान संस्थान (IMP) Instituto de Investigación de Patología Molecular (IMP) معهد أبحاث علم الأمراض الجزيئي (IMP) Institut de Recherche en Pathologie Moléculaire (IMP) Научно-исследовательский институт молекулярной патологии (IMP) Instituto de Pesquisa de Patologia Molecular (IMP)